Latest Breaking News On - Amy mahery - Page 1 : comparemela.com

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

United statesJohn climacoJenene thomasAmy maheryCompany on twitterSecurities exchangePharmaceuticals incBerubicin clinical development progressCompany board of directorsExchange commissionPharmaceuticals fast track designation for berubicinData safety monitoring boardOverall survivalFinancial resultsFull yearFast track designation

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Cli

Lead program, Berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from DSMB to proceed without modification in potentially pivotal GBM studyBerubicin study enrollment completed; Topline data expected in first half of 2025Clinical progress represents important steps towa.

United statesJohn climacoAmy maheryJenene thomasPharmaceuticals fast track designation for berubicinSecurities exchangeCompany on twitterBerubicin clinical development progressCompany board of directorsExchange commissionPharmaceuticals incData safety monitoring boardOverall survivalFinancial resultsFull yearFast track designation

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights .

United statesAmy maheryJohn climacoPharmaceuticals incNews networkCompany board of directorsPharmaceuticals fast track designation for berubicinBerubicin clinical development progressData safety monitoring boardClinical development progress theOverall survivalFinancial resultsFull yearFast track designationOrphan drug designation

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJenene thomasAmy maheryJohn climacoPharmaceuticals fast track designation for berubicinBerubicin clinical development progressSecurities exchangeCompany board of directorsExchange commissionCompany on twitterPharmaceuticals incData safety monitoring boardOverall survivalFinancial resultsFull yearFast track designation

BioMedNewsBreaks – CNS Pharmaceuticals Inc (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of Directors

BioMedNewsBreaks – CNS Pharmaceuticals Inc (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesAmy maheryCns pharmaceuticalsLife sciencesPharmaceuticals incBiomedical sciences biomedSerono incRoivant sciencesMerck kgaaMerck kgaBiomedical sciencesDynamic brand portfolioPhones only